155 related articles for article (PubMed ID: 10630728)
1. Metabolic coronary-flow regulation and exogenous nitric oxide in human coronary artery disease: assessment by intravenous administration of nitroglycerin.
Kal JE; Van Wezel HB; Porsius M; Vergroesen I; Spaan JA
J Cardiovasc Pharmacol; 2000 Jan; 35(1):7-15. PubMed ID: 10630728
[TBL] [Abstract][Full Text] [Related]
2. The effect of nitroglycerin on pacing-induced changes in myocardial oxygen consumption and metabolic coronary vasodilation in patients with coronary artery disease.
Kal JE; Vergroesen I; van Wezel HB
Anesth Analg; 1999 Feb; 88(2):271-8. PubMed ID: 9972740
[TBL] [Abstract][Full Text] [Related]
3. A critical appraisal of the rate pressure product as index of myocardial oxygen consumption for the study of metabolic coronary flow regulation.
Kal JE; Van Wezel HB; Vergroesen I
Int J Cardiol; 1999 Oct; 71(2):141-8. PubMed ID: 10574399
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease.
Kal JE; Spaan JA; van Wezel HB
J Cardiovasc Pharmacol; 2002 Feb; 39(2):225-33. PubMed ID: 11791008
[TBL] [Abstract][Full Text] [Related]
5. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts.
Crystal GJ; Zhou X; Gurevicius J; Ramez Salem M
Anesth Analg; 1998 Nov; 87(5):994-1001. PubMed ID: 9806671
[TBL] [Abstract][Full Text] [Related]
6. Myocardial oxygen supply:demand ratio as reference for coronary vasodilatory drug effects in humans.
Vergroesen I; Kal JE; Spaan JA; Van Wezel HB
Heart; 1997 Aug; 78(2):117-26. PubMed ID: 9326983
[TBL] [Abstract][Full Text] [Related]
7. Myocardial and systemic effects of nitroglycerin, given awake and during anaesthesia in coronary patients.
Moffitt EA; Sethna DH; Gray RJ; Raymond MJ; Bussell JA; Matloff JM
Can Anaesth Soc J; 1983 Jul; 30(4):352-9. PubMed ID: 6409387
[TBL] [Abstract][Full Text] [Related]
8. Comparative effect of intravenous dipyridamole and sublingual nitroglycerin on coronary hemodynamics and myocardial metabolism at rest and during atrial pacing in patients with coronary artery disease.
Arrotti J; Gunnar RM; Ward J; Loeb HS
Clin Cardiol; 1980 Dec; 3(6):365-70. PubMed ID: 6780257
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease.
Valsson F; Lundin S; Kirnö K; Hedner T; Houltz E; Saito Y; Ricksten SE
Anesth Analg; 1999 Feb; 88(2):279-85. PubMed ID: 9972741
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of right atrial, right ventricular apical, and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency in patients with coronary artery disease.
Kyriakides ZS; Antoniadis A; Iliodromitis E; Michelakakis N; Kremastinos DT
Br Heart J; 1994 Jun; 71(6):536-40. PubMed ID: 8043333
[TBL] [Abstract][Full Text] [Related]
11. Coronary and systemic hemodynamic effects of the putative nitric oxide donor, FK 409, in comparison with nitroglycerin in conscious and anesthetized dogs.
Drieu la Rochelle C; Lainée P; Grosset A; O'Connor SE
J Cardiovasc Pharmacol; 1995 Oct; 26(4):555-63. PubMed ID: 8569215
[TBL] [Abstract][Full Text] [Related]
12. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
[TBL] [Abstract][Full Text] [Related]
13. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
14. Nitroglycerin reduces myocardial oxygen consumption during exercise despite vascular tolerance.
Parent R; Leblanc N; Lavallée M
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1226-34. PubMed ID: 16272202
[TBL] [Abstract][Full Text] [Related]
15. Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide.
Matsunaga T; Okumura K; Tsunoda R; Tayama S; Tabuchi T; Yasue H
Am J Physiol; 1996 Feb; 270(2 Pt 2):H427-34. PubMed ID: 8779816
[TBL] [Abstract][Full Text] [Related]
16. [Effect of intracoronary nifedipine on coronary sinus blood flow and myocardial oxygen consumption in patients with coronary artery disease].
Schanzenbächer P; Liebau G; Deeg P; Kochsiek K
Z Kardiol; 1982 Jun; 71(6):393-7. PubMed ID: 7124058
[TBL] [Abstract][Full Text] [Related]
17. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G
J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived nitric oxide does not modulate metabolic coronary vasodilation induced by tachycardia in dogs.
Katsuda Y; Egashira K; Akatsuka Y; Narishige T; Shimokawa H; Takeshita A
J Cardiovasc Pharmacol; 1995 Sep; 26(3):437-44. PubMed ID: 8583786
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitric oxide and noradrenergic activation in the posterior hypothalamus on arterial pressure tolerance to nitroglycerin in rats.
Guettler DL; Ma SX
J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):98-106. PubMed ID: 18375750
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure.
Ehara S; Nakamura Y; Matsumoto K; Hasegawa T; Shimada K; Takagi M; Hanatani A; Izumi Y; Terashima M; Yoshiyama M
Heart Vessels; 2013 Sep; 28(5):596-605. PubMed ID: 23014927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
